CAR-T

Bold Predictions for Medtech in 2021
Bold Predictions for Medtech in 2021
Medical Devices and Diagnostics Industry
devices
Medtech
COVID-19
remote patient monitoring
telemedicine
home care
digital medicine
artificial intelligence
machine learning
robotic surgery
3D printing
Joe Biden
gene editing
microbiome
CAR-T
Flag link:
Factor Bioscience spins out a new cell therapy player with eyes on the clinic within 2 years
Factor Bioscience spins out a new cell therapy player with eyes on the clinic within 2 years
Endpoints
Factor Bioscience
cell therapy
MRNA
CAR-T
Flag link:
Autolus buckles down, chopping 20% of staff and seeking partner for a lead CAR-T program
Autolus buckles down, chopping 20% of staff and seeking partner for a lead CAR-T program
Endpoints
Autolus Therapeutics
ESMO
CAR-T
diffuse large B-cell lymphoma
layoffs
Flag link:
Chasing BMS, J&J files BCMA CAR-T for multiple myeloma to FDA
Chasing BMS, J&J files BCMA CAR-T for multiple myeloma to FDA
Pharmaforum
JNJ
Janssen
Multiple Myeloma
CAR-T
cilta-cel
FDA
Bristol-Myers Squibb
ide-cel
Flag link:
ASH: Allogene's off-the-shelf CAR-T posts 60% response rate in fiercely competitive BCMA field
ASH: Allogene's off-the-shelf CAR-T posts 60% response rate in fiercely competitive BCMA field
Fierce Biotech
ASH2020
Allogene
CAR-T
Flag link:
Bayer Leaps into CAR T-Cell Therapy Scene with Atara Biotherapeutics Collaboration
Bayer Leaps into CAR T-Cell Therapy Scene with Atara Biotherapeutics Collaboration
BioSpace
Bayer
CAR-T
cell therapy
Atara
Flag link:
FDA gives Cellectis all clear after patient death halted off-the-shelf CAR-T trial
FDA gives Cellectis all clear after patient death halted off-the-shelf CAR-T trial
Endpoints
Cellectis
FDA
patient deaths
CAR-T
clinical trials
Multiple Myeloma
Flag link:
JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China
JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China
Endpoints
JW Therapeutics
IPOs
CAR-T
liso-cel
China
Hong Kong
Juno Therapeutics
WuXi AppTec
Flag link:
CRISPR stock slides as CAR-T death overshadows signs of efficacy
CRISPR stock slides as CAR-T death overshadows signs of efficacy
Fierce Biotech
CRISPR
CRISPR Therapeutics
CAR-T
patient deaths
Flag link:
EdiGene raises $67M to take gene-editing therapies into humans
EdiGene raises $67M to take gene-editing therapies into humans
Fierce Biotech
EdiGene
gene editing
CAR-T
beta thalassemia
ET-01
ET-02
Flag link:
Poseida shares plunge after death in solid tumor CAR-T trial, clinical hold
Poseida shares plunge after death in solid tumor CAR-T trial, clinical hold
Fierce Biotech
Poseida Therapeutics
solid tumors
CAR-T
SEC
prostate cancer
Flag link:
Juno joint venture seeks IPO haul to bring CAR-Ts to China
Juno joint venture seeks IPO haul to bring CAR-Ts to China
Fierce Biotech
JW Therapeutics
Juno Therapeutics
WuXi AppTech
IPOs
Hong Kong
CAR-T
Flag link:
Novartis says CAR-T cancer therapy works in second lymphoma type
Novartis says CAR-T cancer therapy works in second lymphoma type
BioPharma Dive
Novartis
Kymriah
follicular lymphoma
CAR-T
Flag link:
FDA approves MorphoSys, Incyte’s drug for vulnerable lymphoma population
FDA approves MorphoSys, Incyte’s drug for vulnerable lymphoma population
MedCity News
FDA
Monjuvi
CAR-T
MorphoSys
Incyte
diffuse large B-cell lymphoma
Flag link:
Gilead’s Kite gains some height after second CAR-T approval in US
Gilead’s Kite gains some height after second CAR-T approval in US
Pharmaforum
Gilead Sciences
Kite Pharma
CAR-T
Flag link:
Gilead’s Kite Pharma gets FDA nod for second CAR-T cell therapy
Gilead’s Kite Pharma gets FDA nod for second CAR-T cell therapy
MedCity News
Gilead Sciences
CAR-T
KTE-X19
Tecartus
FDA
Kite Pharma
Flag link:
Death in Cellectis off-the-shelf CAR-T trial triggers FDA hold
Death in Cellectis off-the-shelf CAR-T trial triggers FDA hold
Fierce Biotech
Cellectis
CAR-T
UCARCS1A
Multiple Myeloma
patient deaths
FDA
Flag link:
Bayer-backed Century buys Empirica to create brain cancer CAR-Ts
Bayer-backed Century buys Empirica to create brain cancer CAR-Ts
Fierce Biotech
Century Therapeutics
Empirica
cell therapies
brain cancer
glioblastoma
CAR-T
Flag link:
Sana Biotechnology raises more than $700M for cell, gene therapy efforts
Sana Biotechnology raises more than $700M for cell, gene therapy efforts
MedCity News
Sana Biotechnology
Juno Therapeutics
CAR-T
Flag link:
Poseida Therapeutics guns again for IPO
Poseida Therapeutics guns again for IPO
Fierce Biotech
Poseida Therapeutics
CAR-T
IPOs
Flag link:

Pages